Articles from CanSino Biologics Inc

CanSinoBIO Reports Growth in First Nine Months: Commercialization Accelerates Across Multiple Products as Platform Innovation Opens New Avenues for Growth

By CanSino Biologics Inc · Via ACN Newswire · October 27, 2026

Overseas Growth Gathers Momentum as CanSinoBIO's Global Strategy Unlocks New Opportunities

By CanSino Biologics Inc · Via ACN Newswire · August 27, 2026

CanSinoBIO's NDA for Td5cp Adolescent and Adult Accepted, Further Strengthening Its Diversified Vaccine Pipeline

By CanSino Biologics Inc · Via ACN Newswire · August 16, 2026

CanSinoBIO's Menhycia (R) Secures Expanded Age Indication, Unlock Broader Long-Term Growth Potential

By CanSino Biologics Inc · Via ACN Newswire · February 24, 2026